FDA Drug Application (206040) for LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number206040
Product Number001
FormTABLET;ORAL
Dosage150MG;300MG;600MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
Active IngredientLAMIVUDINE;ZIDOVUDINE;EFAVIRENZ

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by MYLAN LABS LTD